financetom
Business
financetom
/
Business
/
United Natural Foods Beats On Q4 Earnings, Thanks To Inflation And Higher Volumes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Natural Foods Beats On Q4 Earnings, Thanks To Inflation And Higher Volumes
Oct 2, 2024 10:10 PM

Grocery wholesaler United Natural Foods Inc ( UNFI ) shares are surging after the fourth-quarter earnings.

The company reported a sales increase of 10% Y/Y to $8.15 billion, beating the analyst consensus estimate of $7.94 billion, thanks to inflation and improving unit volume that turned positive toward quarter-end.

Gross margin expanded to 13.7% from 13.0% last year on lower shrink expense. The gross profit upped 15.5% Y/Y to $1.1 billion.

Adjusted EBITDA jumped 53.8% Y/Y to $143 million. Adjusted EPS of $0.01 beat the consensus loss estimate of $0.10.

Free cash flow stood at $71 million in the quarter. As of August 3, the company had approximately $40 million in cash, plus the unused capacity of approximately $1.24 billion under its asset-based lending facility.

Outlook: United Natural Foods ( UNFI ) sees FY25 sales of $30.3 billion – $30.8 billion (vs. consensus of $30.9 billion) and adjusted EPS of $0.20-$0.80 versus the consensus of $0.57.

Sandy Douglas, UNFI's Chief Executive Officer said, “We are also actioning key elements of our updated strategy that has resulted from our ongoing board- and management-led financial review, which we expect will drive accelerating performance and create sustainable value for our customers and suppliers.”

”During fiscal 2024, we drove strong same customer growth, extended our agreement with our largest customer, realized approximately $150 million dollars in benefits from structural efficiency initiatives, significantly reduced shrink, lengthened the maturity on our term loan, and onboarded our new President and CFO, Matteo Tarditi.”

Investors can gain exposure to the stock via Northern Lights Fund Trust III Counterpoint Quantitative Equity ETF and Invesco Exchange-Traded Fund Trust II Invesco S&P SmallCap 600 Revenue ETF .

Price Action: UNFI shares are up 9.51% at $18.42 premarket at the last check Tuesday.

Read Next:

US Stocks Set For Shaky Start Ahead Of JOLTS Data, Nike Earnings: Strategist Says These 3 Structural Drivers Support ‘Buying The Dip’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing
SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing
Mar 6, 2025
02:51 AM EST, 03/06/2025 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on March 03, 2025, sold 20,000 shares in SpringWorks Therapeutics ( SWTX ) for $1,084,592. Following the Form 4 filing with the SEC, Edris has control over a total of 169,712 common shares of the company, with 169,712 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465925021008/xslF345X05/tm258294-2_4seq1.xml ...
Akero Therapeutics Insider Sold Shares Worth $2,243,213, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $2,243,213, According to a Recent SEC Filing
Mar 6, 2025
02:48 AM EST, 03/06/2025 (MT Newswires) -- Jonathan Young, Chief Operating Officer, on March 04, 2025, sold 50,000 shares in Akero Therapeutics ( AKRO ) for $2,243,213. Following the Form 4 filing with the SEC, Young has control over a total of 261,147 common shares of the company, with 201,147 shares held directly and 60,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017025033998/xslF345X05/ownership.xml...
Novartis not panicking over potential US pharmaceutical tariffs, chairman says
Novartis not panicking over potential US pharmaceutical tariffs, chairman says
Mar 6, 2025
ZURICH, March 6 (Reuters) - Novartis is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the drug maker's Chairman Joerg Reinhardt said in an interview published on Thursday. President Trump last month flagged potential import duties of about 25% on pharmaceuticals as part of measures affecting other industries, including semiconductors and automobiles, as...
Advanced Energy Industries Insider Sold Shares Worth $2,155,137, According to a Recent SEC Filing
Advanced Energy Industries Insider Sold Shares Worth $2,155,137, According to a Recent SEC Filing
Mar 6, 2025
02:50 AM EST, 03/06/2025 (MT Newswires) -- Eduardo Bernal Acebedo, Executive Vice President and Chief Operations Officer, on March 03, 2025, sold 19,309 shares in Advanced Energy Industries ( AEIS ) for $2,155,137. Following the Form 4 filing with the SEC, Acebedo has control over a total of 19,822 common shares of the company, with 19,822 shares held directly. SEC...
Copyright 2023-2025 - www.financetom.com All Rights Reserved